Scholarlink

Objective and design <p>The kynurenine (KYN) pathway is activated in acute kidney disease, including crescentic glomerulonephritis (CGN), an immune-mediated life-threatening syndrome characterized by rapid loss of renal function. The non-invasive measurement of KP metabolites may have clinical diagnostic or prognostic value, but has never been systematically studied using sensitive analytical tools.</p> Methods <p>We have recently developed and validated a sensitive and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to measure a comprehensive panel of tryptophan (TRP) catabolic intermediates in blood and urine. We used a novel model of CGN to approximate human biochemical and physiological parameters.</p> Results <p>We show that for a period of 28 days after the onset of the disease, monitoring plasma KP is not informative as it is likely to reflect an accumulation of uremic retention solutes and does not allow to follow the activity of the disease over time. In contrast, the urinary metabolic profile is noteworthy, with an early and significant yet transient increase in urinary KYN/TRP ratio levels. Urinary KYN/TRP ratio is independent of proteinuria.</p> Conclusion <p>These findings suggest that increased urinary KYN/TRP ratio levels by LC/MSMS in patients with CGN reflect early disease activity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Time course profiling of the kynurenine pathway activity in a pig model of crescentic glomerulonephritis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月29日

查看全文
  • Zahia Nadour,
  • Julien Dang,
  • Léa Resmini,
  • Virginie Poindessous,
  • Pierre-Louis Tharaux,
  • Nicolas Pallet

摘要

Objective and design

The kynurenine (KYN) pathway is activated in acute kidney disease, including crescentic glomerulonephritis (CGN), an immune-mediated life-threatening syndrome characterized by rapid loss of renal function. The non-invasive measurement of KP metabolites may have clinical diagnostic or prognostic value, but has never been systematically studied using sensitive analytical tools.

Methods

We have recently developed and validated a sensitive and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to measure a comprehensive panel of tryptophan (TRP) catabolic intermediates in blood and urine. We used a novel model of CGN to approximate human biochemical and physiological parameters.

Results

We show that for a period of 28 days after the onset of the disease, monitoring plasma KP is not informative as it is likely to reflect an accumulation of uremic retention solutes and does not allow to follow the activity of the disease over time. In contrast, the urinary metabolic profile is noteworthy, with an early and significant yet transient increase in urinary KYN/TRP ratio levels. Urinary KYN/TRP ratio is independent of proteinuria.

Conclusion

These findings suggest that increased urinary KYN/TRP ratio levels by LC/MSMS in patients with CGN reflect early disease activity.